gMG clinical trials at UCSF
1 research study open to eligible people
Generalized Myasthenia Gravis (gMG) is a disease that weakens muscles. UCSF is studying how a drug called Ravulizumab works in children with gMG. This trial looks at how safe it is and how it affects the body.
Showing trials for
Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)
open to all eligible people
The primary purpose of this study is to characterize the pharmacokinetics and pharmacodynamics of treatment with ravulizumab intravenous infusion in pediatric participants with gMG.
San Francisco, California and other locations
Our lead scientists for gMG research studies include Jonathan Strober.
Last updated: